Unruptured Intracranial Aneurysms
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
AM-PharmaNetherlands - Utrecht
1 programBrain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial AneurysmsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AM-PharmaBrain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial Aneurysms
Clinical Trials (1)
NCT01490463AM-PharmaBrain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial Aneurysms
Brain Lesions Following Endovascular and Surgical Treatment of Unruptured Intracranial Aneurysms
Start: Aug 2011Est. completion: Jan 2013
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space